Your session is about to expire
← Back to Search
Retinal Prosthesis
New VPU with bipolar stimulation for Retinitis Pigmentosa
N/A
Recruiting
Led By James Weiland
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8 hours
Awards & highlights
Study Summary
This trial will test new ways to stimulate and train the retina in order to improve the vision of those with retinal prosthesis.
Eligible Conditions
- Retinitis Pigmentosa
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 8 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in shape perception
Percent change in stimulus thresholds
Trial Design
1Treatment groups
Experimental Treatment
Group I: Retinal stimulationExperimental Treatment2 Interventions
Alternative stimulus patterns will be tested (vs. baseline). The intervention is the alternative stimulus pattern. The intervention will be tested only in the clinic vs. baseline. The subject will go home with baseline settings. The two alternative stimulus patterns to be tested are asymmetric waveforms and bipolar stimulus.
Find a Location
Who is running the clinical trial?
National Eye Institute (NEI)NIH
546 Previous Clinical Trials
1,401,908 Total Patients Enrolled
23 Trials studying Retinitis Pigmentosa
14,351 Patients Enrolled for Retinitis Pigmentosa
University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,933 Total Patients Enrolled
3 Trials studying Retinitis Pigmentosa
520 Patients Enrolled for Retinitis Pigmentosa
James WeilandPrincipal Investigator - University of Michigan
University of Michigan
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must have an Argus II Retinal Prosthesis implanted.
Research Study Groups:
This trial has the following groups:- Group 1: Retinal stimulation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger